ArticleJournal of cancer research and clinical oncology2026
Long-term benefit from high-dose ifosfamide in sarcoma depends on sustained prior control and timely intervention: a machine learning analysis.
Michael Hoberger et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.